Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUR2B is a regulatory subunit of the ATP-sensitive potassium (KATP) channel, crucial for linking cellular metabolism to electrical activity in smooth muscle and some neurons. It forms a hetero-octameric complex with Kir6.2 subunits and is involved in regulating muscle contraction and neuronal activity by modulating KATP channel activity in response to cellular energy status. Sulphonylureas can bind to SUR2B, but with lower affinity than SUR1.
Modulates KATP channel activity by binding ATP and ADP, and interacting with sulphonylureas. ATP hydrolysis by NBD2 affects channel gating.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulphonylurea receptor subunit SUR2B (SUR2B).